Michelson's VivoSight moves into Japan
This article was originally published in Clinica
Executive Summary
UK imaging company Michelson Diagnostics has appointed Integral Corporation exclusive distributor of its recently CE-marked VivoSight scanner in Japan. Tokyo-based Integral will market and sell the system, which uses multi-Beam optical coherence tomography, for non-clinical use in cosmetic research settings. The VivoSight was CE marked in October for clinical use in Europe and non-clinical use worldwide. The scanner is designed to provide images of sub-surface tissue at a "far higher" resolution than other imaging modalities, according to Orpington-based Michelson. When positioned over tissue, the system's hand-held probe can capture either two- or three-dimensional images of a 5mm square region and highlight tissue microstructure features such as epidermis, dermis and sub-surface blood vessels.